Algernon Pharmaceuticals Inc. C.AGN

AGN now investigating CKD treatment

[StockHawk1]

For everyone interested in biotech or pharma companies, Algernon Pharmaceuticals (AGN.c AGNPF) is a clinical-stage drug development and repurposing company that is currently investigating treatments for IPF, chronic cough, stroke, and TBI.

AGN also recently received a Notice of Allowance from the US Patent and Trademark Office for its patent application for its chronic kidney disease drug, Repirinast.

More info here: https://www.algernonpharmaceuticals.com/news-media/news-releases/detail/181/algernon-pharmaceuticals-announces-notice-of-allowance-for

[Whalewatcher1]

StawkHawk1, so how do you think these guys will pay for CKD trial? They can only raise $1.2M on rights offering, don't have the funds to complete current trials/ideas, they spin out stroke program as can't finance it. Why can't management pick an indication and do a trial right, not spend huge portion of investors money on stock promotion (they call it marketing, however need an actual

[C10H12N2]

Dude, surfely, you're aware that it's merely a handful of penny stock bots doing the corps bidding here. You'll never get a legitimate debate regarding any questions deemed adversarial to towing the corporate line. Smoke and Mirrors. Yes, they have no money to run any clinicl trials, but don't let that stop the CEO from spending all the money on ineffective "marketing"